Trial intelligence / Profile preview

Docetaxel in Locally Advanced Breast Cancer

NCT00206453Phase 2Terminated

Sponsor
Baylor Breast Care Center
Start
Jan 2002
Primary completion
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in breast cancer, sponsored by Baylor Breast Care Center. Started Jan 2002; status: terminated.

02

Drugs

docetaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00206453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00206453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call